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InﬂammationUsing rheumatoid arthritis (RA) and periodontitis mouse models, we demonstrate that RA and peri-
odontitis share many pathological features, such as deregulated cytokine production, increased
immune-cell inﬁltration, increased expression of Toll-like receptors (TLRs), and enhanced osteoclast
activity and bone erosion. We reveal that genetic deletion of cathepsin K (Ctsk) caused a radical
reduction in inﬂammation and bone erosion within RA joint capsules and periodontal lesions, a
drastic decrease in immune-cell inﬁltration, and a signiﬁcant reduction in osteoclasts, macrophages,
dendritic and T-cells. Deﬁciency of Ctsk greatly decreased the expression of TLR-4, 5, and 9 and their
downstream cytokines in periodontal gingival epithelial lesions and synovial RA lesions. Hence, Ctsk
may be targeted to treat RA and periodontitis simultaneously due to its shared osteoimmune role.
 2015 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
Periodontitis is one of the most common oral inﬂammatory
diseases. This disease may result in the destruction of periodontal
tissues and alveolar bone, which ultimately leads to tooth loss
[1,2]. Multiple bacterial infections are important factors for peri-
odontitis [3]. During this process, different kinds of cells partici-
pate in the immune response, such as polymorphonuclear
neutrophils (PMNs), macrophages, dendritic cells (DCs), and T cells
[4]. The affected cells can induce the expression of many cytokines,
including the receptor activator of nuclear factor kb ligand (RANKL)which can promote osteoclast (OC) formation and the following
periodontal bone resorption [5–7].
The development of rheumatoid arthritis (RA) is followed by the
activation of the immune system, resulting in the inﬁltration of
immune cells in the synovial membrane of the joint [8]. RA is con-
sidered to be a chronic, immune-regulated inﬂammatory disease,
which will cause an excessive inﬂammatory response, cartilage
and bone destruction, and eventually structural damage and loss
of function. RA is associated with signiﬁcant morbidity and an
increased risk of mortality [9]. A variety of studies have demon-
strated a close association between RA and periodontitis [10–12].
Periodontitis and rheumatoid arthritis are inﬂammatory diseases
enhanced by dysregulation of the immune response in the progres-
sion of these diseases [11,13]. Clinical studies show that RA is more
prevalent in individuals with periodontitis and vice versa in com-
parison to the general population [14,15]. One of the major obsta-
cles to ﬁnding a cure for both RA and periodontitis is that the
unknown factors that drive persistent immune cellular activation
and inﬂammatory mediator synthesis remain elusive [4,16].
Toll-like receptors (TLRs), which are an important part of the
innate and adaptive immune system, have been proposed as
driving the inﬂammation in RA. In the development of periodonti-
tis, TLRs have also been shown to have a critical role in the
1332 L. Hao et al. / FEBS Letters 589 (2015) 1331–1339periodontitis lesion area [17]. Cathepsin K (Ctsk) is a peptidase C1
protein family member that is known to be a lysosomal cysteine
protease [18]. The function of cathepsin K in periodontitis has
not been characterized and the role of Ctsk in TLR signaling
pathways in periodontitis is unknown. There is limited study on
the role of Ctsk in TLR signaling pathways in RA. The common
pathogenesis between RA and periodontitis mediated by Ctsk has
not yet been evaluated.
Therefore, we sought to understand the underlying pathogene-
sis by which Ctsk regulates both RA and periodontitis. Ctsk knock-
out mice were used in this study to investigate the function of Ctsk
in the development of RA and periodontitis. Our data reveal that
RA and periodontitis have a common aberrant high TLRs signaling
pathogenesis and suggest the critical osteoimmune function of
Ctsk in rheumatoid arthritis and periodontitis.2. Materials and methods
For complete Materials and Methods, please see Supplemental
Materials and Methods.
2.1. Infection with bacterial strains
The bacteria used in this study were Porphyromonas gingivalis
W50 (ATCC: 53978), Treponema denticola (ATCC: 35404) and
Tannerella forsythia (ATCC: 43037). These strains were grown
under anaerobic conditions (80% N2, 10% H2, and 10% CO2) at
37 C in a Coy anaerobic chamber and were cultured [19,20]. An
equal volume of sterile 2% (w/v) CMC was added, mixed thor-
oughly, and 100 ll (5  109 cells of P. gingivalis per ml, 5  109 cells
of T. denticola per ml and T. forsythia per ml) was administered by
oral and anal topical application according to a previously
described protocol [21,22].
2.2. Animals
Seven to eight-week-old female wild-type (WT) C57BL/6J mice,
purchased from the Jackson Laboratory were used for the periodon-
titis experiments. Ctsk/micewere previously generated in our lab
with the C57BL/6J background for periodontitis experiments [23].
C57BL/6J background Ctsk/ and WT mice were crossed with
human TNF-transgenic mice (hTNF-tg) mice to generate hTNF-tg
Ctsk/ and hTNF-tgWTmice for RA experiments. For the periodon-
titis experiments, mice were divided into 4 groups: (1) wild-type
(WT) normal group; (2) Ctsk/ normal group; (3)WT disease group
(bacterial infection); and (4) Ctsk/ disease group (bacterial infec-
tion). For the RA experiments, mice were divided into 4 groups: (1)
WT mice, (2) Ctsk/ mice, (3) hTNF-tg mice, and (4) hTNF-tg
Ctsk/ mice. Experiments in the current study were performed in
triplicate on three independent occasions, and N = 5 for each group,
resulting in a total sample number of N = 15 for each group. This
study was approved by the University of Alabama at Birmingham
(UAB) Institutional Animal Care and Use Committee (IACUC). The
animals were maintained at the UAB animal facility and were given
distilled water and allowed to feed freely.
3. Results
3.1. Knockout of Ctsk resulted in bone protection and the decrease of
TLRs expression in the periodontitis lesion area
To test the possible role during the progression of periodontitis
lesions mediated by Ctsk, we used the periodontal disease mouse
model established by our previous study [21]. Samples from WT
and Ctsk/ mice with or without infection were analyzed bymethylene blue staining eight weeks after initial infection
(Fig. 1A). Vertical and horizontal observation showed that there
was no obvious bone resorption in the control groupswithout infec-
tion. Bone resorption was signiﬁcant in theWT periodontitis group,
but not in the Ctsk/ periodontitis group (red arrows) (Fig. 1A).
However, the hTNFtg mice did not show spontaneous periodontitis
at 16 weeks (Fig. S1). H&E staining of theperiodontal tissues showed
that bone destruction, as well as monocyte inﬁltration (red arrows),
increased in theWT periodontitis group (Fig. 1B). Quantitative anal-
ysis of the alveolar bone resorption area and the length of alveolar
bone loss revealed that each measurement was signiﬁcantly higher
in theWTperiodontitis group than in theCtsk/periodontitis group
(Fig. 1C and D). TLRs are important for the innate immune response
in inﬂammatory diseases. In bacterial-mediated inﬂammation, TLR4
recognizes lipopolysaccharide (LPS), TLR5 recognizes ﬂagellin, and
TLR9 recognizes bacterial DNA and CpG oligodeoxynucleotide,
which are critical antigens that cause an immune response [24]. In
the periodontitis lesion area, the expression of TLR4, 5, and 9 at eight
weeks decreased signiﬁcantly in the Ctsk/ periodontitis group
compared to the WT periodontitis group (Fig. 1E–J).
3.2. Ctsk knockout provided bone protective effects as well as a
decreased innate immune response in RA
In our current study, we used the human TNF-transgenic mouse
model to conﬁrm the results (Fig. 2). X-ray analysis also showed
signiﬁcant bone destruction (white arrow) in the knee joint and
hind ankle joint in the hTNF-tg group compared to the hTNF-tg
Ctsk/ group at 24 weeks (Fig. 2A–D). SO staining also showed
that the cartilage has been protected in the hTNF-tg Ctsk/ group
(Fig. 2E and F). We also conﬁrmed the expression of Ctsk in WT,
Ctsk/, hTNF-Tg and Ctsk/ hTNF-Tg groups at 24 weeks.
(Fig. S2). Ctsk was successfully depleted in the Ctsk knockout group
in the RA and periodontitis lesion areas. To explore whether these
TLRs are involved in the development of RA in the same manner as
in the periodontitis lesion areas, and to determine whether Ctsk
has an effect on the immune response during the progression of
RA, we performed immunohistochemistry (IHC) staining of the
RA lesion areas of different groups at 24 weeks (Fig. 2G–L). A signif-
icant increase of TLR4-positive, TLR5-positive, and TLR9-positive
cells was observed in the RA lesion area in hTNF-tg mice compared
to Ctsk/ hTNF-tg mice, Ctsk/ mice, or WT mice (Fig. 2G–L).
3.3. Ctsk knockout reduced immune-related cells in RA and
periodontitis lesion areas
DCs are antigen presenting cells which will differentiate after
exposure to proinﬂammatory cytokines, immune complexes, or
endogenous inﬂammatory factors that are recognized by TLR
[25]. Our results showed that there was signiﬁcantly higher
expression of the DCs marker CD11c in the RA lesion area in
hTNF-tg mice compared to hTNF-tg Ctsk/ mice (Fig. 3A–C).
Similarly, there was a signiﬁcant increase of CD11c-positive DCs
in the periodontitis lesion area in the WT periodontitis group com-
pared to the Ctsk/ periodontitis group (Fig. 3D–F). This indicates
that knockout of Ctsk has an impact on antigen-presenting cells in
the RA and periodontitis lesion areas. We further performed IHC
analysis of the macrophage-speciﬁc marker F4/80 on mutant
mouse hTNF-tg RA (Fig. 4A). Quantiﬁcation results showed that
the F4/80-positive cells were lower in the Ctsk/ RA groups
(Fig. 4B). The current results revealed that OCs were activated in
the RA group (Fig. 4C). The OC numbers in the Ctsk/ hTNF-tg
groups were signiﬁcantly lower than in the hTNF-tg groups
(Fig. 4D). Since activation of OCs not only depends on osteoblasts,
but also the immune system, this indicates that Ctsk has an impor-
tant function in the immune system. Interestingly, the IHC stain
Fig. 1. Knockout of Ctsk resulted in bone protective effects in the periodontitis lesion area. (A) Methylene blue staining of the maxilla tooth from the WT and Ctsk/ groups
with and without infection at 8 weeks after initial infection. Red arrows indicate vertical bone resorption. White dot areas indicate horizontal bone resorption. (B) H&E stain
of the periodontal tissue from the WT and Ctsk/ groups with and without infection. Columns 2 are enlarged images of boxed areas in column 1. Red arrows indicate
monocyte inﬁltration. Scale bar: 100 lm. (D) Quantiﬁcation of horizontal alveolar bone resorption area in ‘‘A’’. (C) Quantiﬁcation of alveolar bone resorption in ‘‘B’’. (E–J) IHC
stains and quantiﬁcation of TLR4-positive (E, H), TLR5-positive (F, I), and TLR9-positive (Brown) (G, J) cells in gingival areas in the WT and Ctsk/ groups with and without
infection at 8 weeks. Red arrows indicate positive cells. Inf: infection. **: P < 0.01, ***: P < 0.001. N.S: no signiﬁcance. N = 5, repeated three times. Scale bar: 25 lm.
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demonstrated that Ctsk has a role in immune cells as well as osteo-
clasts since F4/80-positive macrophages and TRAP-positive cells
decreased signiﬁcantly in the Ctsk/ periodontitis group compared
to the WT periodontitis group (Fig. 4E–H). In order for Ctsk to have
an effect on the immune system, the immune cells must express
Ctsk. Therefore we determined whether Ctsk was expressed in
macrophages or DCs by co-localization analysis (Fig. 4J). The
results showed that Ctsk was expressed in macrophages and DCs.
To further conﬁrm our ﬁndings, we applied CD3 immunoﬂuores-
cence (IF) stain to examine T cell activation (Fig. 5). T lymphocytes
are important immune effector cells that can be divided into
cytotoxic T lymphocytes, helper T lymphocytes, and suppressor T
lymphocytes. The co-surface marker of lymphocytes, CD3, can be
used to detect activated T lymphocytes in inﬂammation [26]. The
results showed that CD3-positive T cells decreased signiﬁcantly
in the lesion areas in the Ctsk/ hTNF-tg group and Ctsk/ peri-
odontitis group (Fig. 5). These results indicated that Ctsk knockout
may affect the immune response that occurs in both the RA and
periodontitis lesion areas.
3.4. Inhibition of Ctsk reduced the expression of pro-inﬂammatory
cytokines in the RA and periodontitis lesion areas
In the periodontitis lesion area at 8 weeks, the protein expres-
sion of TNF-a, IL-6 and IL-12 was signiﬁcantly decreased in the
Ctsk/ periodontitis group when compared to the WT periodonti-
tis group (Fig. 6A). qRT-PCR showed that the mRNA expression ofTLR genes (i.e. TLR4, TLR5 and TLR9) was signiﬁcantly increased in
the WT periodontitis group compared to the other groups
(Fig. 6B). ELISA was used to evaluate the effect of Ctsk knockout
on the protein expression levels of TNF-a, IL-1a, IL-6, IL-17, and
IL-10, which are related to the TLR signaling pathway in inﬂamma-
tory RA tissues. In the RA lesion area at 24 weeks, the protein
expression of TNF-a, IL-6, IL-1a, and IL-17 was signiﬁcantly
increased in hTNF-tg mice compared to the normal control group
(Fig. 6C). qRT-PCR revealed that the mRNA expression of Ctsk,
pro-inﬂammatory genes (i.e. IL-12b) and TLR genes (i.e. TLR4,
TLR5 and TLR9) was signiﬁcantly increased in the hTNF-tg group
compared to the other groups (Fig. 6D). To conﬁrm the possible
role of Ctsk in the immune cell response to bacterial-induced
inﬂammation through TLR, we used LPS and CpG to stimulate
mouse bone marrow (MBM)-derived dendritic cells in vitro
(Fig. 6E–G). Our in vitro data showed that Ctsk knockout greatly
inhibited cytokine expression-related NF-jB activation. The
expression of TNF-a, IL-6 and IL-12 in WT and Ctsk/ DCs
increased in CpG- and LPS-stimulated groups compared to unstim-
ulated groups (Fig. 6E). However, the expression of inﬂammatory
cytokines in the Ctsk/ CpG stimulation group was signiﬁcantly
lower than in the WT CpG stimulation group. In the LPS stimula-
tion group, although expression of inﬂammatory cytokines
increased in WT and Ctsk/ MBM DCs, the difference between
the two groups was not statistically signiﬁcant (P > 0.05). The
mRNA expression of IL-6 was consistent with the ELISA results,
which was signiﬁcantly lower in the Ctsk/ CpG stimulation group
than the WT CpG stimulation group. Although IL-6 gene expression
Fig. 2. Ctsk Knockout provided bone protection in rheumatoid arthritis (RA). (A–D) Radiographic and quantiﬁcation analysis of joints from theWT, Ctsk/, hTNF-Tg and Ctsk/
 hTNF-Tg groups at 24 weeks. X-ray analysis showed severe joint bone destruction (white arrows). (E, F) Safranin O stain and quantiﬁcation analysis of joints from different
groups. SO stain showed decreased cartilage in the hTNF-Tg group. Scale bar: 100 lm. (G–L) Immunohistochemical (IHC) stains and quantiﬁcation of TLR4-positive cells (G, J),
TLR5-positive cells (H, K), and TLR9-positive cells (I, L) in RA lesion areas in different groups at 24 weeks. **: P < 0.01, ***: P < 0.001. N.S: no signiﬁcance. N = 5, repeated three
times. Scale bar: 125 lm.
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LPS-stimulated WT group, there was no signiﬁcant difference in
IL-6 protein expression between LPS-stimulated Ctsk/ and WT
groups. The expression of inﬂammatory factors (i.e. IL-12b) in the
CpG-stimulated Ctsk/ group was lower than the CpG-stimulated
WT group, while expression of these inﬂammatory cytokines
showed an opposite trend in the LPS-stimulated groups (Fig. 6F).
Although Ctsk knockout has a signiﬁcant impact on TLR9-mediatedexpression of inﬂammatory cytokines, its speciﬁc role in the signal
transduction pathway is still unknown. Therefore, we tested the
mRNA expression of MyD88, TRAF6, IRAK1 and IRAK4, which are
important in signal transduction pathways associated with TLR9.
Results showed that Ctsk knockout inﬂuenced the CpG-stimulated
expression ofMyD88, TRAF6, IRAK1 and IRAK4 in the TLR9 signaling
pathway (Fig. 6G). In the case of LPS stimulation, IRAK1 decreased
in the Ctsk-/- group, the expression of MyD88 and IRAK4 didn’t
Fig. 3. Knockout of Ctsk reduced CD11c-positive dendritic cells in RA and periodontitis lesion areas. (A–C) Immunoﬂuorescence (IF) staining and quantiﬁcation of CD11c-
positive (Texas red) dendritic cells (DCs) in the RA lesion area in different groups at 24 weeks. Boxed areas in ‘‘A’’ are magniﬁed in columns 1 and 2 of ‘‘B’’. Boxed areas in ‘‘B’’
are magniﬁed in column 3 of ‘‘B’’. White arrows indicate positive cells. (D–F) IF staining and quantiﬁcation of CD11c-positive (Texas red) DCs in the periodontitis lesion area in
different groups at 8 weeks. Boxed areas in ‘‘D’’ are magniﬁed in columns 1 and 2 of ‘‘E’’. Boxed areas in ‘‘E’’ are magniﬁed in column 3 of ‘‘E’’. White arrows indicate positive
cells. S: synovial, AD: articular disc, G: gingival, Inf: infection. *: P < 0.05, **: P < 0.01. N.S: no signiﬁcance. N = 5, repeated three times. Scale bar: 50 lm.
L. Hao et al. / FEBS Letters 589 (2015) 1331–1339 1335change in the Ctsk/ and WT groups, and TRAF6 levels increased in
the Ctsk/ group compared to the WT group (Fig. 6G).
4. Discussion
A previous study showed that knockout of Ctsk may partially
inhibit bone destruction in hTNFtg mice [27]. Our current study
suggests that the pathogenesis by which Ctsk mediates the
immune response in RA and periodontitis is similar in the two dis-
eases. Retrospective studies in recent years show that there is an
interaction between periodontal disease and rheumatoid arthritis,
compared with healthy people. The incidence rate of periodontal
disease is higher in patients with rheumatoid arthritis, and in peri-
odontal disease patients the incidence of rheumatoid arthritis is
higher [28]. Recent studies have established the link between RA
and periodontitis, claiming that periodontitis might be a causal fac-
tor that will enhance the severity of RA and vice versa, and these
two diseases are highly associated at the epidemiological level
[10,14]. Synovial tissue in the RA lesion area is considered to be
the inﬂammation center and a source of osteoclast differentiation
for the development of RA [29–31], while periodontitis is alwayspreceded by inﬂammation of gingival tissue (gingivitis) [32]. Our
present ﬁndings demonstrate that DCs, macrophages, and T cells
are inﬁltrated extensively in the RA synovial tissue and periodon-
titis gingival tissue. The synovial ﬁbroblasts and gingival epithelial
cells may have similar functions in RA and periodontitis: initiating
the innate response, activating immature DCs to mature DCs, and
mediating inﬂammation cytokine expression and OC activation
which further tissue damage. The inhibition of Ctsk results in the
suppression of immune cell expression, osteoclast activation, and
the prevention of articular cartilage erosion and alveolar bone loss
in the hTNF-tg mouse models and periodontitis mouse model
respectively. Cathepsin K was ﬁrst discovered and cloned by our
lab [33,34], which was reported to play important function in
immune cells [35]. Additional studies are needed to distinguish
between these possibilities [36]. Previous studies have shown that
Ctsk knockout has no effect on OC differentiation [23]. However,
we found a signiﬁcant decrease in OCs in the Ctsk/ RA and
Ctsk/ periodontitis groups, indicating Ctsk’s role in inﬂammation.
Our current results suggest that Ctsk may mediate RA and peri-
odontitis bone destruction not only through its known function
in OCs, but also through immune cell-mediated activation of OCs.
Fig. 4. Knockout of Ctsk reduced macrophages and osteoclasts in RA and periodontitis lesion areas. (A, B) IHC stains and quantiﬁcation of F4/80 positive (Brown) cells in RA
lesion areas in different groups at 24 weeks. Second column of ‘‘A’’ are enlarged images of red boxed areas. Red arrows indicate positive cells. (C, D) TRAP stain and
quantiﬁcation of osteoclasts in RA lesion areas in different groups at 24 weeks. (E, F) IHC stains and quantiﬁcation of F4/80 positive (Brown) macrophages in the periodontitis
lesion areas of the WT and Ctsk/ groups with and without infection at 8 weeks. Red arrow and white inset box of enlarged image show positive cells. (G, H) TRAP stain and
quantiﬁcation of osteoclasts in the periodontitis lesion areas in different groups at 8 weeks. (I) Normal serum at the same area served as a negative control. (J) Ctsk localizes to
DCs and macrophages in the periodontitis lesion area. White arrows and white inset boxes of enlarged images show double positive cells. Inf: infection, DIC: differential
interference contrast. **: P < 0.01, ***: P < 0.001. N.S: no signiﬁcance. N = 5, repeated three times. Scale bar: 100 lm.
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reduce the inﬂammation of RA in a rat model [37]. Macrophages
and DCs are critically involved in the pathogenesis of RA as shown
in our current studies. Not only do they produce a variety of pro-
inﬂammatory cytokines and chemokines, but they also contributeto the cartilage and bone destruction in RA [38]. Our current study
showed that Ctsk may play a critical role in the immune response
of RA and in the periodontitis lesion area. IF was used in our study
to detect the expression of Ctsk in immune cells, which would be a
prerequisite for Ctsk having any function in the immune system.
Fig. 5. Knockout of Ctsk reduced CD3-positive T cells in RA and periodontitis lesion areas. (A–C) IF staining and quantiﬁcation of CD3-positive (GFP) T cells in the RA lesion
area in different groups at 24 weeks. Boxed areas in ‘‘A’’ are magniﬁed in columns 1 and 2 of ‘‘B’’. Boxed areas in ‘‘B’’ are magniﬁed in column 3 of ‘‘B’’. White arrows indicate
positive cells. (D–F) IF staining and quantiﬁcation of CD3-positive (Texas red) T cells in the periodontitis lesion area in different groups at 8 weeks. Boxed areas in ‘‘D’’ are
magniﬁed in columns 1 and 2 of ‘‘E’’. Boxed areas in ‘‘E’’ are magniﬁed in column 3 of ‘‘E’’. White arrows indicate positive cells. S: synovial, AD: articular disc, G: gingival, Inf:
infection. **: P < 0.01, ***: P < 0.001. N.S: no signiﬁcance. N = 5, repeated three times. Scale bar: 50 lm.
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as macrophages and DCs. We have shown that knocking out Ctsk
has reduced the pro-inﬂammatory cytokine expression in RA and
periodontitis lesion tissues. Many of these effector molecules
appear to be common to both diseases. While the effects of cytoki-
nes on normal cellular processes are important, it is their
purported roles in the immune response, which may involve exces-
sive production, dysregulation, or inadequate inhibition, that may
be critical for the progression of both RA and periodontitis disease.
Periodontitis has very similar cytokine proﬁles to RA based on our
current study, which consists of persistently high levels of pro-
inﬂammatory cytokines (e.g. TNF-a). In a rheumatoid arthritis rat
model, Asagiri et al. veriﬁed that Ctsk possibly mediates the
immune response of DCs in vitro [37]. These results showed that,
as a dual role protein, Ctsk not only participated in osteoclastic
bone resorption, but was also involved in immune cell-mediated
inﬂammation.
Importantly, the present study provides new insights into the
possible connections of the immune response to RA and periodon-
titis. In the periodontitis mouse model, knockout of Ctsk resulted in
similar decreases in TLR4, 5 and 9. Although the RA models we
used do not involve bacteria-induced inﬂammation lesions, ourdata suggested that TLR4, 5 and 9 also decreased signiﬁcantly in
the hTNF-tg Ctsk/ group. This indicates that TLR4, 5 and 9 may
play similar functions of mediating the immune response in RA
and periodontitis lesion areas and that Ctsk may regulate this pro-
cess. ELISA and qRT-PCR results conﬁrmed the in vivo IHC stain in
both RA knee tissues and periodontitis lesion tissues. These results
underscore the possibility that future therapies could block Ctsk in
RA and periodontitis by speciﬁc small molecule inhibitors or gene
therapy. However, the pathogenesis by which Ctsk functions in
TLRs activation is still unclear. The current view is that cathepsins
may make TLRs form a correct protein structure through
proteolytic processing, thereby initiating the antigen recognition
process [39,40]. MyD88-related transcription level, which is an
important component of the activation of the downstream path-
way, was signiﬁcantly inhibited in Ctsk/ DCs with CpG stimula-
tion. However, MyD88, TRAF6, IRAK1, and IRAK4 transcription
levels were not fully inhibited in LPS-stimulated Ctsk/ DCs.
In conclusion, our study ﬁrst demonstrated that bone resorption
and exaggerated inﬂammatory host responses in periodontitis and
RA are mediated by Ctsk through the TLR4, 5 and 9 signaling path-
ways in DCs. These observations highlight a central pathogenic role
for Ctsk in these settings and identify Ctsk as a directed, logical
Fig. 6. Ctsk knockout or inhibition reduced the expression of pro-inﬂammatory cytokines in vivo (RA and periodontitis lesion areas) and in vitro (WT and Ctsk/ DCs). (A)
Cytokine expression levels of TNF-a, IL-6 and IL-12 in the periodontitis lesion area were detected by ELISA at 8 weeks. (B) qRT-PCR of TLR genes in different groups. b-actin
was used as an endogenous control. C, Cytokine expression levels of TNF-a, IL-1a, IL-6, IL-17 and IL-10 in the RA lesion at 24 weeks were detected by ELISA. (D) qRT-PCR of
pro-inﬂammatory genes (i.e. IL-12b) and TLR genes in the RA lesion area at 24 weeks. (E) MBM-derived DCs from WT and Ctsk/mice were stimulated with LPS (200 ng/ml)
or CpG (1 lM/ml) for 12 h. The production of TNF-a, IL-6, and IL-12 was measured by ELISA. (F) qRT-PCR analysis of TNFa, IL-6, and IL-12b expression in WT and Ctsk/MBM-
derived DCs stimulated with LPS or CpG as above. (G) MBM-derived DCs from WT and Ctsk/ mice were stimulated with LPS or CpG for 12 h. The expressions of TLRs
downstream signaling pathway were detected by qRT-PCR. Inf: infection. *: P < 0.05, **: P < 0.01, ***: P < 0.001. N.S: no signiﬁcance. N = 5, repeated three times.
1338 L. Hao et al. / FEBS Letters 589 (2015) 1331–1339target for the suppression of cartilage and periodontal bone
destruction. Indeed, optimal control of RA or periodontitis inﬂam-
mation is most likely to preserve a range of homeostatic properties
for both diseases. Collectively, Ctsk may be one possible target to
treat RA and periodontitis simultaneously due to its shared
pathogenesis.
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